Showing posts with label superbug. Show all posts
Showing posts with label superbug. Show all posts

Thursday, July 26, 2012

Superbug resistance follows seasonal drug use

Reuters – 2 hrs 15 mins ago NEW YORK (Reuters Health) - Bacteria - including the MRSA superbug -may be more resistant to our most powerful antibiotics after a winter spurt of prescriptions, says a new study.

"Antibiotic use tends to go up in the winter months because they are inappropriately prescribed and that usually shows up a few months later in hospitals in the form of antibiotic resistance," said Dr. Ramanan Laxminarayan, who led the new study at Princeton University, New Jersey.

Widespread inappropriate use of antibiotics is driving the increase in resistance by encouraging the survival of bugs that can fight the drugs, according to the Centers for Disease Control and Prevention.

"We're seeing an inability to treat patients who have resistant infections; they stay in hospital for longer, incur more hospitalization costs, and are more likely to die," said Laxminarayan.

For the new study, published in the journal Clinical Infectious Diseases, Laxminarayan and his team looked at more than 1.5 billion prescriptions filled at U.S. pharmacies between 1999 and 2007. The prescriptions only accounted for antibiotic use outside hospitals.

They also looked at the results of nearly 5 million tests for antibiotic resistance in E. coli and more than 2 million for MRSA - methicillin-resistant Staphylococcus aureus - collected from 300 labs across the U.S.

When prescriptions for two commonly prescribed classes of antibiotics - penicillins such as ampicillin, which is used to treat ailments like ear infections, and fluoroquinolones such as ciprofloxacin, commonly used to treat urinary tract infections - increased in winter, researchers saw an uptick in E. coli and MRSA resistance to those same antibiotics about a month later.

For example, when penicillin prescriptions increased from 3.3 million in July 2006 to 5.8 million in January 2007, the rate of E. coli resistant to ampicillin rose from 42 to 45 percent.

MRSA resistance to ciprofloxacin rose by 5 percent to 38 percent as prescriptions per month increased by almost a million between July 2006 and January 2007.

E. coli resistance to ciprofloxacin gradually increased from 2 percent to 17 percent between 1999 and 2007, with the difference between summer and winter also growing over time, Laxminarayan told Reuters Health in an email.

THE RIGHT ANTIBIOTICS

This sort of time-related data can add to evidence that antibiotic use causes bacterial resistance, said Dr. Alastair Hay, who has done research on antibiotic resistance at Bristol University in the UK.

However, it doesn't prove antibiotics are the only cause of bacterial resistance; for example, in the winter months resistant bacteria might be more easily passed from person to person, added Hay, who wasn't involved in the study.

And while the study did look at common bacteria, there are a lot of other bugs out there, said Dr. Betsy Foxman, who studies antibiotic resistance at the University of Michigan.

The study was also limited because researchers weren't able to account for antibiotic use in hospitals, which is also seasonal.

National campaigns to prevent bacterial resistance focus on making sure patients get the right antibiotics for the right amount of time.

"There's an idea that we can control resistance in hospitals with good stewardship programs, and we think those are important, but they are limited in importance by what's going on going outside of the hospital setting as well," said Laxminarayan.

According to the CDC, only 48 percent of hospitals currently have such a program in place.

"An important way to control resistance in hospitals is to ensure that people get a seasonal influenza vaccine, including health care workers, and that we really target our campaign against antibiotic use during the winter months," said Laxminarayan.

"Patients also need to ask themselves if they need an antibiotic," said Foxman.

SOURCE: http://bit.ly/KOBHLk Clinical Infectious Diseases, online July 1, 2012.



View the Original article

Saturday, June 16, 2012

Superbug gonorrhea spreading across Europe

Reuters – Mon, Jun 11, 2012 LONDON (Reuters) - "Superbug" strains of gonorrhea which are becoming untreatable accounted for almost one in 10 cases of the sexually transmitted disease in Europe in 2010, more than double the rate of the year before, health officials said on Monday.

The drug-resistant strains are also spreading fast across the continent, officials warned. They were found in 17 European countries in 2010, seven more than in the previous year.

Gonorrhea was the second most common sexually transmitted infection (STI) in Europe in 2010, with more than 32,000 infections, data from the Stockholm-based European Centre for Disease Prevention and Control (ECDC) showed.

Even though chlamydia was the most frequently reported STI, with more than 345,000 cases, the ECDC's director singled out gonorrhea as presenting a "critical situation".

Marc Sprenger said the increase in cases of superbug strains meant there was a risk gonorrhea may become an untreatable disease in the near future.

The proportion of gonorrhea cases with resistance to the antibiotic recommended to treat the disease, cefixime, rose from 4 percent in 2009 to 9 percent in 2010.

The ECDC report follows a warning from the World Health Organisation that virtually untreatable forms of drug-resistant gonorrhea were spreading around the world.

Gonorrhea is a bacterial infection which, if left untreated, can lead to pelvic inflammatory disease, ectopic pregnancies, stillbirths, severe eye infections in babies, and infertility in men and women.

VIGILANT

It is one of the most common sexually transmitted diseases in the world and is most prevalent in South and Southeast Asia and sub-Saharan Africa.

In the United States alone, the number of cases is estimated at about 700,000 a year, according to the Centers for Disease Control and Prevention (CDC).

The emergence of drug-resistant gonorrhea is caused by unregulated access to and overuse of antibiotics, which help fuel genetic mutations within the bacteria.

"Public health experts and clinicians need to be aware of the current critical situation and should be vigilant for treatment failures," Sprenger said in a statement.

Experts say the best way to reduce the risk of even greater resistance developing - beyond the urgent need to develop new drugs - is to rapidly and accurately diagnose the disease and then treat it with combinations of two or more types of antibiotics at the same time.

This technique is used in the treatment of some other infections like tuberculosis in an attempt to make it more difficult for the bacteria to learn how to overcome the drugs.

The ECDC's sexually transmitted infections report covered data and trends on five STIs - syphilis, congenital syphilis, gonorrhea, chlamydia and lymphogranuloma venereum (LGV) - in the EU and European Economic Area from 1990 to 2010.

It found diverging trends in sexually transmitted diseases across Europe, with a rapidly increasing trend for chlamydia and slightly decreasing trends for gonorrhea and syphilis.

Genital chlamydia infections are caused by Chlamydia trachomatis bacteria which can irreversibly damage a woman's reproductive organs.

Although the disease is easily treated with antibiotics, infections can remain undiagnosed because many patients - 70 percent of women and 50 percent of men - have no symptoms and so are unaware they are carrying and passing on the infection.

(Editing by Pravin Char)



View the Original article

Tuesday, April 24, 2012

Gene points to Achilles' heel in MRSA superbug

"http://l.yimg.com/bt/api/res/1.2/t9zkbEWsQx3sNUlU0rpbjw--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTcwO3E9ODU7dz03MA--/http://media.zenfs.com/en_us/News/afp.com/000_APW2003041402003.jpg" width

View the Original article

Monday, April 23, 2012

Gene points to Achilles' heel in MRSA superbug

"http://l.yimg.com/bt/api/res/1.2/t9zkbEWsQx3sNUlU0rpbjw--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTcwO3E9ODU7dz03MA--/http://media.zenfs.com/en_us/News/afp.com/000_APW2003041402003.jpg" width

View the Original article